Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a home device help stroke survivors walk better?

NCT ID NCT05849532

Symptom relief Sponsor: University of Illinois at Chicago Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study tests whether using a home-based electrical stimulation device, combined with specific exercises, can help people with chronic stroke improve their walking, balance, and mobility. Thirty adults who had a stroke more than six months ago will use the device during training sessions at home over 12 weeks. The goal is to see if this approach is safe, practical, and effective for everyday recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Functional Electrical Stimulation (FES) device
What this could lead to
If successful, this could offer a practical home-based therapy to improve walking and balance for people with chronic stroke, reducing fall risk and enhancing daily function.
What could go wrong
This is a small early feasibility study with only 30 participants, so results may not apply to everyone. The home-based setup relies on technology and internet access, which could limit participation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2022

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age group: 18-90 years. 2. Presence of unilateral hemiparesis. 3. Onset of stroke (\> 6 months). 4. Ability to walk independently with or without an assistive device for at least 300 ft. 5. Can understand and communicate in English and can verbalize discomfort or pain in English 6. Use of smartphone on a daily basis 7. Availability of internet/Wi-Fi at home Exclusion Criteria: 1. Body weight more than 250 lbs. 2. Heel bone density measurement using an ultrasound device. Individuals classified as osteoporotic (i.e., with a T-score \< -2) will be excluded. 3. Cognitive impairment (Montreal Cognitive assessment score \<26/30) 4. Verbal Aphasia (i.e \<71% score on Mississippi Aphasia Screening) 5. Severe depression (\> 15 points on geriatric depression scale) 6. Any neurological condition other than stroke. 7. Uncontrolled and/or untreated hypertension/hypotension, uncontrolled and/or untreated diabetes and any musculoskeletal, neuromuscular or systemic diagnosis . 8. Recent major surgery (\< 6 months) or hospitalization (\< 3 months). 9. Deep venous thrombosis. 10. Past or current history of any type of active cancer 11. Peripheral nerve injury or neuropathy in the affected limb with motor disability. 12. Uncontrolled high blood pressure/angina. 13. Skin condition not tolerant with FES therapy. 14. Past or current history of uncontrolled/controlled epilepsy or any other types of seizure disorders 15. Botox treatment within the last 5 months. 16. Pacemaker users. \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic stroke are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Illinois at Chicago

    RECRUITING

    Chicago, Illinois, 60612-4225, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.